Katrien Oude Rengerink
Overview
Explore the profile of Katrien Oude Rengerink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou G, Dael N, Verweij S, Balafas S, Mubarik S, Oude Rengerink K, et al.
Eur Respir Rev
. 2025 Feb;
34(175).
PMID: 39971395
Background: Up-to-date evidence from European studies on long-term vaccine effectiveness (VE) of COVID-19 vaccines is lacking. This review aimed to evaluate effectiveness and durability of primary vaccine series and boosters...
2.
Verweij S, Ahmed W, Zhou G, Mavridis D, Nikolakopoulos S, Elferink A, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(5):e5810.
PMID: 38720409
Background: Randomized controlled trials are considered the gold standard in regulatory decision making, as observational studies are known to have important methodological limitations. However, real-world evidence may be helpful in...
3.
Langedijk A, Oude Rengerink K, Harding E, Wensing A, van Slooten R, Israeli Y, et al.
Cytokine
. 2024 Feb;
176:156530.
PMID: 38306791
A novel host-protein score (called MMBV) helps to distinguish bacterial from viral infection by combining the blood concentrations of three biomarkers: tumour necrosis factor related apoptosis inducing ligand (TRAIL), interferon...
4.
Zhou G, de Vos S, Schuiling-Veninga C, Bos J, Oude Rengerink K, Pasmooij A, et al.
Clin Epidemiol
. 2023 Sep;
15:923-937.
PMID: 37694159
Background: Repurposing registered drugs could reduce coronavirus disease (COVID-19) burden before novel drugs are authorized. Little is known about how the pandemic and imposed restrictions changed their dispensing. We aimed...
5.
Zhou G, Verweij S, Bijlsma M, de Vos S, Oude Rengerink K, Pasmooij A, et al.
BMJ Open Respir Res
. 2023 Aug;
10(1).
PMID: 37640510
Objective: Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive. We aimed to systematically evaluate published studies on repurposed drugs for the prevention of laboratory-confirmed SARS-CoV-2 infection and/or COVID-19...
6.
Jones M, Palmer K, Pathirana M, Cecatti J, Filho O, Marions L, et al.
Lancet
. 2022 Nov;
400(10364):1681-1692.
PMID: 36366885
Background: Induction of labour is one of the most common obstetric interventions globally. Balloon catheters and vaginal prostaglandins are widely used to ripen the cervix in labour induction. We aimed...
7.
Mitroiu M, Teerenstra S, Oude Rengerink K, Petavy F, Roes K
Pharm Stat
. 2022 Jun;
21(5):1037-1057.
PMID: 35678545
Estimands aim to incorporate intercurrent events in design, data collection and estimation of treatment effects in clinical trials. Our aim was to understand what estimands may correspond to efficacy analyses...
8.
Billard M, Wildenbeest J, Bont L, Nair H, McCracken J, Oude Rengerink K
J Clin Epidemiol
. 2022 Feb;
147:11-20.
PMID: 35217153
Objectives: Year-to-year variation in respiratory viruses may result in lower attack rates than expected. We aimed to illustrate the impact of year-to-year variation in attack rates on the likelihood of...
9.
Van Stigt A, Oude Rengerink K, Bloemenkamp K, de Waal W, Prevaes S, Le T, et al.
BMC Infect Dis
. 2022 Feb;
22(1):152.
PMID: 35164699
Background: Many studies support the protective effect of breastfeeding on respiratory tract infections. Although infant formulas have been developed to provide adequate nutritional solutions, many components in human milk contributing...
10.
Linssen R, Bem R, Kapitein B, Oude Rengerink K, Otten M, den Hollander B, et al.
Eur J Pediatr
. 2021 Apr;
180(10):3141-3149.
PMID: 33891158
Respiratory syncytial virus (RSV) bronchiolitis causes substantial morbidity and mortality in young children, but insight into the burden of RSV bronchiolitis on pediatric intensive care units (PICUs) is limited. We...